1 / 8

Nuclear Medicine Market is expected to garner $8,207.5 million by 2022

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global nuclear medicine market.This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth. Exhaustive analysis of the global radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future. Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies.<br>

srushtih123
Download Presentation

Nuclear Medicine Market is expected to garner $8,207.5 million by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Nuclear Medicine Market Report Contains Key Vendor Analysis, Vendor Landscape Global Opportunity Analysis and Industry Forecast, 2014-2022

  2. Nuclear Medicine Market “The diagnostics segment held a dominant share in the radiopharmaceuticals market in 2015, and is expected to maintain its lead during the forecast period. Asia-Pacific is projected to continue to dominate the market throughout the forecast period.” 

  3. Nuclear Medicine Market Overview Radiopharmaceuticals Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8,207.5 million by 2022. The global radiopharmaceuticals market is poised to grow at a significant pace, owing to growing demand for non-invasive techniques, availability of effective cancer treatment, and ability to observe the functioning of the organ from outside the body. Access Full Summary at : https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market Furthermore, increasing incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, mounting call for nuclear imaging techniques, and advancements in radiotracers are expected to open new avenues in the radiopharmaceuticals market.  

  4. Nuclear Medicine Market The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only helps physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices.  Convenience of the treatment with minimally invasive techniques attracts more patients towards radiopharmaceuticals mode of treatment as compared to chemotherapy. The factors that drive the Radiopharmaceuticals Industry include increasing incidence of cardiac patients and adoption of clear imaging technique, with the help of diagnostic equipment such as PET and SPECT.

  5. Nuclear Medicine Market Key Players • Mallinckrodt plc • General Electric Co. (healthcare division) • Medtronic, Inc. • Bayer AG • Cardinal Health, Inc. • Lantheus Medical Imaging, Inc.

  6. Key Benefits of Nuclear Medicine Market • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global nuclear medicine market. • This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth. • Exhaustive analysis of the global radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future. • Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies. • Key market players within the radiopharmaceuticals market are profiled in this report and their strategies are analyzed thoroughly. This helps in understanding the competitive outlook of the global nuclear medicine market. 

  7. Nuclear Medicine Market North America Europe Asia-Pacific LAMEA

  8. Nuclear Medicine Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/1131 Follow Us On

More Related